OSD
In this webinar experts from the Recipharm team discussed the challenges drug companies face in keeping up with a fast-changing regulatory landscape when developing APIs from R&D to commercial, both for New Chemical Entities (NCEs) and APIs for the generic market.
Key learning objectives
- Understand the challenges posed by the current regulatory environment
- Learn how to address challenges in lifecycle management when developing and maintaining a drug substance
- Learn the benefits of collaboration with an experienced CDMO with an integrated service offering to reduce risks and timelines